Martin Bareš
Biographic Data
| ID | 7637035 |
|---|---|
| NAME | Martin Bareš |
| GIVEN NAMES | Martin |
| FAMILY NAME | Bareš |
| SIGNATURE | BAREŠ M |
| AFFILIATIONS | National Institute of Mental Health |
| ORCID | 0000-0003-0181-6311 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Brain causality alterations in major depressive disorder treatment
Early-phase directional brain connectivity analysis reveals that pharmacological and neurostimulation treatments engage distinct neural oscillatory mechanisms within the first week. Elevated baseline right-dominant α -band causal transmission identifies patients unlikely to respond to pharmacological treatment, enabling alternative interventions before weeks of ineffective therapy. These phase-based causality metrics offer promising biomarkers fo…
Baseline Difference in Quantitative Electroencephalography Variables Between Responders and Non-Responders to Low-Frequency Repetitive Transcranial Magnetic Stimulation in Depression
Repetitive transcranial magnetic stimulation (rTMS) is an effective treatment for depressive disorder, with outcomes approaching 45-55% response and 30-40% remission. Eligible predictors of treatment outcome, however, are still lacking. Few studies have investigated quantitative electroencephalography (QEEG) parameters as predictors of rTMS treatment outcome and none of them have addressed the source localization techniques to predict the respons…
No prominent works on this page.
Baseline Difference in Quantitative Electroencephalography Variables Between Responders and Non-Responders to Low-Frequency Repetitive Transcranial Magnetic Stimulation in Depression
Repetitive transcranial magnetic stimulation (rTMS) is an effective treatment for depressive disorder, with outcomes approaching 45-55% response and 30-40% remission. Eligible predictors of treatment outcome, however, are still lacking. Few studies have investigated quantitative electroencephalography (QEEG) parameters as predictors of rTMS treatment outcome and none of them have addressed the source localization techniques to predict the respons…
Brain causality alterations in major depressive disorder treatment
Early-phase directional brain connectivity analysis reveals that pharmacological and neurostimulation treatments engage distinct neural oscillatory mechanisms within the first week. Elevated baseline right-dominant α -band causal transmission identifies patients unlikely to respond to pharmacological treatment, enabling alternative interventions before weeks of ineffective therapy. These phase-based causality metrics offer promising biomarkers fo…
Functional Brain Connectivity Studies (2 works) · Audiology (1 works) · Baseline (sea (1 works) · Cardiology (1 works) · Causality (physics (1 works) · Clinical trial (1 works) · Electroencephalography (1 works) · Functional magnetic resonance imaging (1 works) · Magnetic resonance imaging (1 works) · Major depressive disorder (1 works)